
{"id":2701,"date":"2024-11-08T10:39:28","date_gmt":"2024-11-08T10:39:28","guid":{"rendered":"https:\/\/hrafnista.is\/?p=2701"},"modified":"2025-02-26T11:40:22","modified_gmt":"2025-02-26T11:40:22","slug":"hrafnista-implements-a-drug-inducer","status":"publish","type":"post","link":"https:\/\/hrafnista.is\/en\/hrafnista-innleidir-lyfjavaka\/","title":{"rendered":"Hrafnista implements a pharmacogen"},"content":{"rendered":"<p>Hrafnista has signed a cooperation agreement with the health technology company Helix on the implementation of the software solution Lyfavaka for its nursing homes.<\/p>\n<p>The implementation of Lyfjavaki is part of Hrafnista's digital journey, and the solution will increase safety in the administration of medicines, ensure the quality of medication registration and provide a better overview of drug selection.<\/p>\n<p>Lyfvaki is an electronic drug registration system that enables nurses to keep track of registrations of drug counts and medication administration by residents. Furthermore, an applet is used to confirm drug administrations. The use of Lyfavaki ensures that the traceability of drug administrations is in accordance with the requirements that apply to such registration.<\/p>\n<p><strong>Better overview and increased security<\/strong><\/p>\n<p>\u201eIt's a pleasure to have Hrafnista join the group of nursing homes and health care facilities that make use of Lyfjavaki. Our solution contributes to a better overview of health care professionals and ensures more accurate and safer medication. It encourages us at Helix on the journey of offering technical solutions for nursing homes and other health care facilities\u201c, says Magn\u00fas M\u00e1r Steinth\u00f3rsson, product manager at Helix.<\/p>\n<p>Gunnur Helgad\u00f3ttir, Director of Health at Hrafnistu, says that the implementation will have a positive effect on household activities. \u201eLyfjavaki is going to increase the professional's overview of medication administration and thereby better ensure quality and safety\u201c.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-2703 size-large\" src=\"https:\/\/hrafnista.is\/wp-content\/smush-webp\/2025\/02\/Picture2_lyfjavaki-1024x679.jpg.webp\" alt=\"\" width=\"1024\" height=\"679\" srcset=\"https:\/\/hrafnista.is\/wp-content\/smush-webp\/2025\/02\/Picture2_lyfjavaki-1024x679.jpg.webp 1024w, https:\/\/hrafnista.is\/wp-content\/smush-webp\/2025\/02\/Picture2_lyfjavaki-300x199.jpg.webp 300w, https:\/\/hrafnista.is\/wp-content\/smush-webp\/2025\/02\/Picture2_lyfjavaki-768x509.jpg.webp 768w, https:\/\/hrafnista.is\/wp-content\/smush-webp\/2025\/02\/Picture2_lyfjavaki.jpg.webp 1221w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/p>\n<p><em>Gunnur Helgad\u00f3ttir, Director of the Health Department of Hrafnista, Mar\u00eda Hrund Stef\u00e1nsd\u00f3ttir, expert in the health department, Oddgeir Reynisson, Director of Operations of Hrafnista, Arna Har\u00f0ard\u00f3ttir, Managing Director of Helix, Mar\u00eda Fj\u00f3la Har\u00f0ard\u00f3ttir, CEO of Hrafnista, Magn\u00fas M\u00e1r Steinth\u00f3rsson, Product Manager at Helix, Harpa Hrund Albertsd\u00f3ttir, expert in the health department of Hrafnista, and Emil Gunnar Einarsson, Director of Business Development at Helix.<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Hrafnista hefur undirrita\u00f0 samstarfssamning vi\u00f0 heilbrig\u00f0ist\u00e6knifyrirt\u00e6ki\u00f0 Helix um innlei\u00f0ingu \u00e1 hugb\u00fana\u00f0arlausninni Lyfjavaka fyrir hj\u00fakrunarheimilin s\u00edn. Innlei\u00f0ing Lyfjavaka er hluti af stafr\u00e6nni vegfer\u00f0 Hrafnistu og mun lausnin auka \u00f6ryggi \u00ed ums\u00fdslu lyfja, tryggja g\u00e6\u00f0i lyfjaskr\u00e1ningar og veita betri yfirs\u00fdn vi\u00f0 lyfjatiltekt. Lyfjavaki er rafr\u00e6nt lyfjaskr\u00e1ningarkerfi sem gerir hj\u00fakrunarfr\u00e6\u00f0ingum kleift a\u00f0 halda utan um skr\u00e1ningar \u00e1 lyfjatiltekt [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2704,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wds_primary_category":0,"footnotes":""},"categories":[32],"tags":[],"class_list":["post-2701","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-frettir"],"acf":[],"_links":{"self":[{"href":"https:\/\/hrafnista.is\/en\/wp-json\/wp\/v2\/posts\/2701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hrafnista.is\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hrafnista.is\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hrafnista.is\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hrafnista.is\/en\/wp-json\/wp\/v2\/comments?post=2701"}],"version-history":[{"count":0,"href":"https:\/\/hrafnista.is\/en\/wp-json\/wp\/v2\/posts\/2701\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hrafnista.is\/en\/wp-json\/wp\/v2\/media\/2704"}],"wp:attachment":[{"href":"https:\/\/hrafnista.is\/en\/wp-json\/wp\/v2\/media?parent=2701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hrafnista.is\/en\/wp-json\/wp\/v2\/categories?post=2701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hrafnista.is\/en\/wp-json\/wp\/v2\/tags?post=2701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}